BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AACVPR Affirms Cardiac Rehabilitation Prolongs Life in Medicare Population


7/15/2010 12:00:42 PM

CHICAGO (June 24, 2009)— A study published in the current issue of the Journal of the American College of Cardiology, shows new evidence that cardiac rehabilitation, an under-utilized service, increases survival in a wide range of patients with heart disease. Philip Ades, MD, a past president of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), participated in a Brandeis University-led study that provides new evidence supporting the benefits of cardiac rehabilitation in older patients with heart disease.

Researchers from Brandeis University (Jose Suaya, MD; William Stason, MD; Donald Shepard, MD), the University of Vermont (Philip Ades, MD), and Harvard University (Prof. Sharon Lise-Normand) conducted an analysis of 601,099 Medicare beneficiaries who were hospitalized in 1997 for coronary heart disease, acute myocardial infarction, angioplasty, stent or bypass surgery and followed up through 2002. Their findings demonstrated that cardiac rehabilitation participation after one of these cardiac events was associated with a significant 21-34% increase in five-year survival rates, similar to that found with the use of other preventive therapies including cholesterol-lowering medications and beta blockers. Mortality reductions also extended to those with congestive heart failure. Ironically, despite these significant benefits, only 12% of eligible patients actually used cardiac rehabilitation services.

“This study clearly shows that cardiac rehabilitation works,” said Ades. “And although it is a covered benefit under Medicare, we can see that cardiac rehab is still severely underused in this population.”

Drs. Suaya, Ades and the other co-authors further commented: “These effects on survival are so convincing that expanded use of cardiac rehabilitation is critical. Cardiac rehabilitation is a low-cost, low-tech intervention that not only raises survival rates but also improves functional capacity, thereby decreasing disability. We should consider implementing quality-of-care performance measures for hospitals and physicians to encourage referral and utilization of cardiac rehabilitation.”

This study was funded by the Centers for Medicare & Medicaid Services.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES